SEC Comment Letter for ASSEMBLY BIOSCIENCES, INC. (ASMB) (CIK 0001426800) (ASMB) — Jan 9, 2018
ASSEMBLY BIOSCIENCES, INC. (ASMB) (CIK 0001426800)
Date: Jan. 9, 2018 · CIK: 0001426800 · Accession: 0000000000-18-000849
AI Filing Summary & Sentiment
Reasoning
Letter
January 5, 2018 Elizabeth H. Lacy General Counsel Assembly Biosciences, Inc. 11711 N. Meridian St., Suite 310 Carmel, Indiana 46032 Assembly Biosciences, Inc. Registration Statement on Form S-3 Filed December 29, 2017 File No. 333-222366Re: Dear Ms. Lacy: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at (202) 551-6761 with any questions. Division of Corporation Finance Office of Healthcare & Insurance cc: Maggie L. Wong, Esq.
Show Raw Text
January 5, 2018
Elizabeth H. Lacy
General Counsel
Assembly Biosciences, Inc.
11711 N. Meridian St., Suite 310
Carmel, Indiana 46032
Assembly Biosciences, Inc.
Registration Statement on Form S-3
Filed December 29, 2017
File No. 333-222366Re:
Dear Ms. Lacy:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Chris Edwards at (202) 551-6761 with any questions.
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Maggie L. Wong, Esq.